Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03881098 · ClinicalTrials.gov registry record · NA

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

A NA study of Lung Cancer, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
2
Study locations

NCT03881098 is a NA study of Lung Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 240 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03881098, a NA study of Lung Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
2
Study locations

Study Summary

This protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.

Conditions Studied

Lung Cancer

Interventions

  • PROCEDURE Venipuncture
  • PROCEDURE Bronchoscopies
  • PROCEDURE Sputum Sample

Study Locations (2)

Colorado

  • Rocky Mountain Regional VAMC - Aurora
  • UCHealth - Metro - Aurora

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2019-12-06
Est. Completion 2028-01
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03881098

The ClinicalTrials.gov registry entry for NCT03881098 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (74% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which Venipuncture is the first listed.

NCT03881098 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03881098 about?

NCT03881098 is a clinical study titled "The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy". This protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.

What is the current status of trial NCT03881098?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2019-12-06. Estimated completion is 2028-01.

What conditions does trial NCT03881098 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03881098?

The interventions under investigation include: Venipuncture (PROCEDURE), Bronchoscopies (PROCEDURE), Sputum Sample (PROCEDURE).

Who is sponsoring clinical trial NCT03881098?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03881098 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.